The Venture Codex Logo

The Venture Codex

Overview

Designs and develops innovative cancer treatments using novel materials.

Total Raised

$58 M

Rounds

3

Links

Verticals

Biotechnology
Chemical
Life Science

Investment History

  1. Equity

    Jun 2021

    $29M

  2. Equity

    May 2020

    $4M

  3. Equity

    Feb 2017

    $25M

Team

Oystein Soug

CEO

Tina Bjørnlund Bønsdorff

Chief Scientific Officer

Øyvind Sverre Bruland

Chief Medical Officer

Orlando Oliveira

Non Executive Director